Ocugen Inc. stock falls Friday, underperforms market
This was the stock's second consecutive day of losses.
Ocugen gets positive EU opinion for ATMP classification for OCU400
Ocugen (OCGN) said it has received a positive opinion from EU regulators for Advanced Therapy Medicinal Product ...
Ocugen Inc. stock falls Thursday, underperforms market
The stock's fall snapped a two-day winning streak.
Yahoo Finance1d
Ocugen, Inc. (OCGN)
MALVERN, Pa., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and ...
Ocugen’s OCU400 granted positive opinion by EMA in retinitis pigmentosa
Ocugen (OCGN) announced that the European Commission has provided a positive opinion from the EMA’s, or European Medicines Agency’s, Committee ...
Largest borrow rate increases among liquid names
Latest data shows the largest indicative borrow rate increases among liquid option names include: Azul (AZUL) 70.69% +1.20, Soho House + Co Inc ...
Nasdaq5d
Ocugen Gets Positive Opinion For OCU400 Advanced Therapy Medicinal Product Classification
(RTTNews) - Ocugen, Inc. (OCGN) Monday said that the European Medicines Agency's (EMA) Committee for Advanced Therapies (CAT) has provided a positive opinion for Advanced Therapy Medicinal Product ...
ETF Daily News15d
Chardan Capital Reiterates Buy Rating for Ocugen (NASDAQ:OCGN)
Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Chardan Capital in a research note issued to investors on Thursday,Benzinga reports.